Biologics / Biotech Manufacturing
We are looking to speak with qa/qc professionals involved in biologics / biotech manufacturing. We are hoping to understand the degree to which pat (on/in line technologies) is impacting traditional tests conducted in the qa/qc lab. Additionally, we would like to understand how this may change over the next 5-10 years and how the role of the traditional qa/qc lab may change, if at all.
This would be for a 1-hour paid phone consult. Please respond with a few brief statements as to your background and relevance for this inquiry.+21 Other Responses
We are looking to understand the following with respect to the biopharma industry on a generic basis :
1. What is the general cost differential for setting up a captive vs. Working with 3rd party vendors?
2.How do biopharma companies build captive centers housing a highly mixed set of activities including r&d, operations, commercial, and more transactional g&a work? (vs. Individual centers of excellence)
3. What types of reporting structures have you seen, specifically for people/resources within captive centers? (direct to a global services group vs. Directly to functions? (cost/benefits for different models)+5 Other Responses
Immunology Market In Europe And North America
I am putting together a market study on 'north america & europe immunology market'.
As a part of my validation process, i am looking to share my findings, market estimates, forecasts and market insights with an expert in the field. I would require a short 15 mins interview with an industry expert, who has expertise in the commercial and market aspects of the following segments.
Immunology diseases: ankylosing spondylitis, crohn’s disease, multiple sclerosis, psoriasis, rheumatoid arthritis, systemic lupus erythematosus, ulcerative colitis
types of drugs: glucocorticoids/nsaids, non-biologic disease modifying drugs (dmards) & biologics
cimzia (certolizumab pegol)
copaxone (glatiramer acetate)
glatopa (glatiramer acetate)
the expert could be a product manager, marketing manager who has previously worked in the marketing of these drugs. It could also be biopharmaceutical consultants, market research experts, scientists who work closely with the products at a commercial level.
Please feel free to get in touch with me if you qualify the above requirements.
annette+7 Other Responses